Plain-English translation of NCT07259343 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing whether a topical cream containing glycomacropeptide—a natural ingredient derived from milk—can help improve symptoms of mild atopic dermatitis (eczema) in children. Researchers want to see if this new treatment can reduce itching, dry skin, and inflammation better than a regular moisturizing cream without the ingredient. The medication is applied directly to affected skin areas twice daily for 4 weeks.
Current treatments for eczema—like steroid creams and other medicated products—can cause unwanted side effects, especially with long-term use. This study exists to explore whether this natural milk-based ingredient offers a gentler alternative that could reduce reliance on traditional medications while still helping children feel better.
You likely qualify if…
You likely don't qualify if…
If your child is selected, you will apply the assigned cream to affected skin areas twice daily for 4 weeks—either the new cream containing the milk ingredient or a regular moisturizing cream (you won't know which one in advance). Your child will attend follow-up appointments so researchers can check how the skin is responding, measure any reduction in itching, and look for signs of improvement. The entire study lasts 4 weeks, and participation is limited to topical (on-skin) application with no blood draws or invasive procedures.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Mexico